Publication | Closed Access

Serum MicroRNA-210 as a Predictive Biomarker for Treatment Response and Prognosis in Patients with Hepatocellular Carcinoma undergoing Transarterial Chemoembolization

Prognostic BiomarkersHepatologyHepatocellular CarcinomaMedicineTreatment ResponsePathologySerum Microrna-210Liver CancerMolecular DiagnosticsMicrorna DetectionOncologyRadiation OncologyTumor Microenvironment